We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+22.33%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$385B
AUM Growth
+$32.1B
Cap. Flow
-$35.1B
Cap. Flow %
-9.14%
Top 10 Hldgs %
30.5%
Holding
11,975
New
1,989
Increased
4,461
Reduced
4,218
Closed
1,130

Sector Composition

Rank Sector Weight
1 Technology 3.78%
2 Healthcare 3.27%
3 Industrials 2.02%
4 Financials 2.02%
5 Consumer Discretionary 1.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GPP
10001
PUT
DELISTED
Green Plains Partners LP
GPP
$115K ﹤0.01%
+14,500
New +$117K
PAE
10002
CALL
DELISTED
PAE Incorporated Class A Common Stock
PAE
$115K ﹤0.01%
+12,500
New +$115K
AQB icon
10003
AquaBounty Technologies
AQB
$7.67M
$114K ﹤0.01%
+651
New +$72.4K
STEX
10004
PUT
Streamex Corp
STEX
$108M
$114K ﹤0.01%
2,920
-260
-8% -$11.4K
GAIA icon
10005
CALL
Gaia
GAIA
$37.1M
$114K ﹤0.01%
+11,500
New +$120K
MG icon
10006
Mistras Group
MG
$576M
$114K ﹤0.01%
14,682
-33,398
-69% -$174K
OTLK icon
10007
Outlook Therapeutics
OTLK
$141M
$114K ﹤0.01%
+4,371
New +$91.3K
HIND
10008
Vyome Holdings
HIND
$15.3M
0
IVC
10009
PUT
DELISTED
Invacare Corporation
IVC
$114K ﹤0.01%
+12,700
New +$106K
EVFM
10010
PUT
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$114K ﹤0.01%
3,160
-3,640
-54% -$132K
DLHC icon
10011
DLH Holdings
DLHC
$67.5M
$113K ﹤0.01%
+12,135
New +$114K
QTTB icon
10012
CALL
Q32 Bio
QTTB
$451M
$113K ﹤0.01%
556
-688
-55% -$133K
QCLS
10013
Q/C Technologies Inc
QCLS
$21.8M
$113K ﹤0.01%
+9
New +$110K
DSKE
10014
PUT
DELISTED
Daseke, Inc. Common Stock
DSKE
$113K ﹤0.01%
+19,500
New +$124K
AHRT
10015
CALL
AH Realty Trust
AHRT
$506M
$112K ﹤0.01%
10,000
-1,800
-15% -$18.2K
CNTY icon
10016
CALL
Century Casinos
CNTY
$36M
$112K ﹤0.01%
17,600
-25,800
-59% -$149K
GNLN icon
10017
Greenlane Holdings
GNLN
$1.22M
0
LBRT icon
10018
PUT
Liberty Energy
LBRT
$3.59B
$112K ﹤0.01%
10,900
-500
-4% -$4.56K
MFIC icon
10019
PUT
MidCap Financial Investment
MFIC
$803M
$112K ﹤0.01%
10,500
-16,600
-61% -$161K
TCRT icon
10020
PUT
Alaunos Therapeutics
TCRT
$4.71M
$112K ﹤0.01%
295
-22
-7% -$8.75K
NTRP icon
10021
NextTrip
NTRP
$21.8M
$112K ﹤0.01%
1,650
+434
+36% +$22.5K
ERF
10022
CALL
DELISTED
Enerplus Corporation
ERF
$112K ﹤0.01%
35,900
+5,800
+19% +$14.1K
LSTA icon
10023
Lisata Therapeutics
LSTA
$9.82M
$111K ﹤0.01%
5,180
+1,409
+37% +$33.4K
LX
10024
CALL
LexinFintech Holdings
LX
$224M
$111K ﹤0.01%
+16,500
New +$118K
SRTY icon
10025
ProShares UltraPro Short Russell2000
SRTY
$65.3M
$111K ﹤0.01%
320
-1,818
-85% -$981K

Similar funds

Ken Griffin's Q4 2020 Portfolio in Review

As of Q4 2020, Ken Griffin held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Ken Griffin withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.8% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Ken Griffin opened a new position in S&P Global worth $114M.

  • Ken Griffin's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
  • Ken Griffin added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
  • Ken Griffin's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
  • Ken Griffin fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
  • Ken Griffin's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
  • Ken Griffin opened 1,989 new positions and closed 1,130 in Q4 2020.
  • Ken Griffin's portfolio value rose 9.1% quarter-over-quarter to $385B.

Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.